Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Johnson and Johnson
Fuji
UBS
Chubb
Dow
QuintilesIMS
Healthtrust

Generated: September 21, 2018

DrugPatentWatch Database Preview

Tajikistan Drug Patents

« Back to Dashboard

Drug Patents in Tajikistan and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
313 ➤ Sign Up 5635485 Apr 1, 2018 telithromycin Sanofi Aventis Us KETEK
Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Army
McKesson
Covington
Chinese Patent Office
Argus Health
Boehringer Ingelheim
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.